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Osteoblast connexin43 modulates skeletal
architecture by regulating both arms of bone
remodeling
Marcus Watkinsa, Susan K. Grimstona, Jin Yi Norrisa, Bertrand Guillotina, Angela Shawa,
Elia Beniashb, and Roberto Civitellia
a

Division of Bone and Mineral Diseases, Departments of Internal Medicine and Cell Biology and Physiology,
Washington University School of Medicine, St. Louis, MO 63110; bSchool of Dental Medicine Center for Craniofacial
Regeneration, McGowan Institute for Regenerative Medicine Bioengineering, University of Pittsburgh, Pittsburgh, PA
15260

ABSTRACT Connexin43 (Cx43) has an important role in skeletal homeostasis, and Cx43 gene
(Gja1) mutations have been linked to oculodentodigital dysplasia (ODDD), a human disorder
characterized by prominent skeletal abnormalities. To determine the function of Cx43 at
early steps of osteogenesis and its role in the ODDD skeletal phenotype, we have used the
Dermo1 promoter to drive Gja1 ablation or induce an ODDD mutation in the chondro-osteogenic linage. Both Gja1 null and ODDD mutant mice develop age-related osteopenia, primarily due to a progressive enlargement of the medullary cavity and cortical thinning. This phenotype is the consequence of a high bone turnover state, with increased endocortical
osteoclast-mediated bone resorption and increased periosteal bone apposition. Increased
bone resorption is a noncell autonomous defect, caused by exuberant stimulation of osteoclastogenesis by Cx43-deficient bone marrow stromal cells, via decreased Opg production.
The latter is part of a broad defect in osteoblast differentiation and function, which also results in abnormal structural and material properties of bone leading to decreased resistance
to mechanical load. Thus Cx43 in osteogenic cells is a critical regulator of both arms of the
bone remodeling cycle, its absence causing structural changes remindful of aged or disused
bone.
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INTRODUCTION
After embryonic development, the skeleton undergoes continuous
remodeling during adult life to ensure biomechanical integrity, rejuvenate aging bone, and repair injuries. Bone remodeling is orchesThis article was published online ahead of print in MBoC in Press (http://www
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Cx43, connexin43; DM1-Cre, Dermo1 promoter driven Cre recombinase; ODDD,
oculodentodigital dysplasia; WTfl, wild-type comparison for Gja1 conditional
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trated by bone-resorbing cells—osteoclasts—and bone-forming
cells—osteoblasts—as well as osteocytes, which are embedded into
the mineralized tissue. In addition to endocrine, paracrine, and autocrine factors, direct cell–cell communication via gap junctions is an
important mechanism by which bone cells coordinate their activities. Abundant gap junctions are present between osteocytic processes, between osteocytes and osteoblasts on the bone surface,
and among osteoblasts (Doty, 1981; Palumbo et al., 1990). Gap
junctions are arrays of hexameric transmembrane channels, called
connexons, formed by protein subunits called connexins. When two
connexons are in register on opposing cells, an aqueous conduit is
formed between two cells—a gap junction channel—which allows
cell-to-cell diffusion of ions, metabolites, and small signaling molecules (Goodenough et al., 1996). Connexons can also exist as individual channels, not paired with apposing connexons, thus functioning as large transmembrane channels (Goodenough and Paul,
2003).
At least three connexins are present in bone cells, each providing unique permeability, ion selectivity, and electric conductance.
Molecular Biology of the Cell

Connexin43 (Cx43) is the most abundant, and multiple lines of evidence have established an important role for Cx43 in skeletal
development and for the function and survival of osteoblasts and
osteocytes (see Stains and Civitelli, 2005; Civitelli et al., 2008, for
review). In particular, germline ablation of Gja1, the gene encoding
for Cx43, results in delayed endochondral and intramembranous
ossification, osteoblast dysfunction, and craniofacial abnormalities
(Lecanda et al., 2000). Because of the perinatal lethality of the germline mutation, tissue-specific Gja1 ablation models have been
developed. We have previously reported that conditional Gja1 ablation driven by a fragment of the Col1A1 promoter, which expresses in committed osteoblasts, results in accrual of a low peak
bone mass and an attenuated response to the anabolic effects of
parathyroid hormone, the consequence of an osteoblast defect
(Chung et al., 2006). In subsequent studies, we have also shown
that these mice have enlarged diaphyses and thin cortices of the
long bones, decreased bone strength, as well as an attenuated
anabolic response to mechanical load (Grimston et al., 2006, 2008).
On the other hand, others have reported that Gja1 ablation in more
mature osteoblasts and osteocytes using the Bgalp promoter
causes no abnormalities in bone mass and does not prevent glucocorticoid-induced bone loss. However, it precludes the effect of
bisphosphonates on apoptosis (Plotkin et al., 2008), decreases cortical bone strength, and causes structural abnormalities similar to
Gja1 deletion in less mature osteoblasts (Bivi et al., 2009).
Further proof of the critical role of Cx43 in skeletal biology is
provided by the identification of Gja1 mutations as the cause of the
autosomal dominant disorder oculodentodigital dysplasia (ODDD),
characterized by multi-organ but primarily skeletal abnormalities,
with syndactyly of the hands, craniofacial dysmorphisms with cranial
hyperostosis, and broad tubular bones (Loddenkemper et al., 2002;
Paznekas et al., 2003; Kjaer et al., 2004). Two Gja1 mouse mutants
have been described with skeletal phenotypes closely resembling
the human disease, including syndactyly and craniofacial malformations (Flenniken et al., 2005; Dobrowolski et al., 2008). These animal
models have also disclosed additional aspects of ODDD that are
unknown or unreported in humans, in particular generalized osteopenia and cortical thinning, which could heavily impact on fracture risk and morbidity in ODDD patients.
Despite significant progress on Cx43 skeletal biology, a number
of key questions remain unanswered. Accumulated in vivo data
suggest that Cx43 may be important at early steps of osteogenesis, perhaps at the time of osteogenic commitment from undifferentiated precursors. Lack of reliable strategies to induce selective
gene ablation in osteogenic precursors has so far precluded testing this hypothesis in vivo. Although osteogenic lineage defects
are evident in Cx43-deficient mice, these defects alone cannot explain all the phenotypic features produced by Gja1 ablation in differentiated osteoblasts, specifically, the widened diaphyses of long
bones (Grimston et al., 2008) and lack of sensitivity to skeletal mechanical unloading (Grimston, Goldberg, Watkins, Brodt, Silva, and
Civitelli, unpublished data), both of which point to a bone resorption abnormality. Aside from in vitro studies suggesting a role of
Cx43 in osteoclast function (Ransjo et al., 2003; Matemba et al.,
2006), bone resorption has not been analyzed in Cx43-deficient
animals. Furthermore, although ODDD mutations are loss-of-function and dominant negative for wild-type Cx43 (Roscoe et al., 2005;
Gong et al., 2007), germline or conditional Gja1 ablation in boneforming cells does not exactly phenocopy ODDD, lacking primarily
the craniofacial malformations. This implies a more complex pathobiology of Cx43 mutations in the cranium relative to the axial and
appendicular skeleton. Finally, introduction of ODDD mutants in
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osteoblasts in vitro alters only expression of late differentiation
genes (McLachlan et al., 2008). These abnormalities are insufficient
to explain the whole ODDD phenotype, raising the possibility that
the ODDD mutants may interfere with normal Cx43 function at earlier phases of osteoblast differentiation or via other mechanisms.
In this study, we have used the Dermo1/Twist2 (DM1) promoter
to drive Cre expression (DM1-Cre) and obtain an early but selective
Gja1 ablation in the chondro-osteogenic lineage (Yu et al., 2003).
We have also used DM1-Cre mice to induce an ODDD mutation
selectively in chondro-osteogenic cells. Dermo1/Twist2 is expressed
at E9.5 in mesodermal tissues (Li et al., 1995), and during endocrondral ossification is present in condensed mesenchyme from which
chondrocytes and osteoblasts are derived (Yu et al., 2003). This genetic approach allows examination of the role of Cx43 at early stages
of osteogenic cell differentiation starting at an early embryologic
stage, up to skeletal adulthood.

RESULTS
DM1;Cre-mediated Gja1 deletion in bone cells
As postnatal Dermo1/Twist2 expression has not been fully characterized, we first assessed gene recombination in DM1;Gja1−/fl (cKO)
adult animals. Cx43 immunoreactive bands were barely detectable
in cKO whole-bone protein extracts of 1-mo-old mice, whereas they
were intense in the Gja1fl/wt (WTfl) extracts (Figure 1A). Conversely,
bands corresponding to β-galactosidase (β-gal) were detected only
in cKO but not in WTfl extract (Figure 1A), consistent with effective
LacZ/Gja1 gene replacement in mutant mice. Gja1 deletion was
also confirmed by positive β-gal staining of tibia sections from
1-mo-old mice. Whereas no staining was observed in sections from
WTfl littermates (Figure 1B, a’–c’), in cKO sections, specific β-gal
staining was observed in cells lining the endocortical surface and in
the periosteum, in cells slightly away from the endosteal bone surface, and in osteocytes (Figure 1Bd’). However, very little if any
β-gal staining was observed in cells on trabecular surfaces or in trabecular osteocytes (Figure 1Be’), and no staining was present in
growth plate chondrocytes (Figure 1Bf’). Because DM1-Cre activity
had been reported in both the growth plate and trabecular bone
(Yu et al., 2003), we mated DM1-Cre mice with ROSA26 mice to
determine the field of postnatal DM1-Cre expression. Clear β-gal
staining was observed in cortical osteoblast and osteocytes (Figure
1Bg’) but also in trabecular osteoblasts (Figure 1Bh’) as well as
growth plate chondrocytes (Figure 1Bi’), suggesting that lack of
β-gal-positive cells in trabecular bone and growth plates of cKO
mice most likely represents very low levels of Gja1 expression,
rather than lack of Cre activity. Importantly, LacZ activity persisted in
cortical bone at least up to 6 mo of age but disappeared by 12 mo
(Supplemental Figure S1). Long-term persistence of recombined
cells may reflect postnatal expression of DM1 or a long life cycle of
the originally recombined chondro-osteogenic precursor cells and
their progeny. Thus DM1-Cre mice represent a good model of selective gene inactivation in the chondro-osteogenic lineage during
the first 6 mo of postnatal life.

Delayed mineralization and low bone mass in cKO
and cODDD mice
All genotypes from both mating schemes were obtained at the expected Mendelian frequency and all were viable. Whole-mount
alizarin red/alcian blue staining of newborn mice revealed only minor dysmorphisms in cKO (Figure 2A), specifically a hypoplastic skull
with smaller parietal and interparietal bones and smaller mandible.
There was also a modest reduction in chest cavity due to short ribs
and slightly shorter tibias and femurs. Newborn DM1;Gja1+/fl(G138R)
Cx43 regulates bone formation/resorption
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Figure 1: Cre-mediated replacement of Gja1. (A) Western blot analysis of whole-bone protein extracts from 3-mo-old
mice showing strong expression of Cx43 in WTfl extracts and barely detectable immunoreactivity in cKO extracts. LacZ/
Gja1 gene replacement was confirmed by the presence of β-gal immunoreactive bands only in cKO protein extracts.
(B) β-gal-stained tibia sections of 1-mo-old mice showing specific β-gal staining present in the cKO but not the WTfl tibia
sections. In the cKO bones, specific β-gal staining was observed in cells lining the endocortical surface, the periosteum,
and in osteocytes (d’–arrows); however, very little β-gal staining was present in the trabeculae (e’), and none in the
growth plate chondrocytes (f’). Comparative sections from 1-mo-old DM1;ROSA26 mice showing β-gal staining in cells
lining the endocortical surface and osteocytes (g’), trabecular osteoblasts (h’), and growth plate chondrocytes (i’).

(cODDD) mice exhibited only skull hypomineralization, without the
dysmorphic features of cKO mice (Figure 2B). At 1 mo of age, skulls
of cKO mice were still significantly hypomineralized, as shown by
μCT, with hypoplastic parietal, interparietal, and occipital bones
relative to control littermates (Figure 2C), whereas cODDD skulls
appeared normally mineralized though slightly smaller than control
littermates at this age (Figure 2D).
Whole-body bone mineral density (BMD) monitored by dualenergy x-ray absorptiometry (DXA) up to 1 yr of age revealed that
both Cx43 cKO and cODDD mice were significantly osteopenic
relative to their respective WT littermates (Figure 2, E and F). This
low bone mass phenotype was evident at 1 mo of age and persisted
until 10 mo in both cKO and cODDD groups. The largest differences
in BMD (∼40%) were observed at younger ages, in both mutant
groups, with a tendency toward partial recovery after 4 mo of age,
and 8–12% difference remaining at 12 mo of age in both groups.

Altered bone structure in Gja1 mutants
Structural analysis was performed by μCT in femurs of 3-mo-old animals postmortem. Macroscopically, femurs of both cKO (Figure 3A)
and cODDD mice (Figure 3G) were ∼10% shorter in both mutants, a
significant difference in both cases (Figure 3, B and H), and in both
cases there was an evident tubulation of the femoral shaft, with
larger medullary cavity. However, no differences in bone volume/
tissue volume or other trabecular structural parameters were observed in either cKO or cODDD femurs relative to their controls
(Supplemental Figure S2). Accordingly, static histomorphometric analysis of cKO bone sections revealed no change in trabecular osteoblast
or osteoclast numbers per bone surface (Supplemental Figure S2).
1242 | M. Watkins et al.

Cross-sectional analysis of the femoral diaphysis confirmed a statistically significant larger total tissue area in both cKO (Figure 3, C
and D; Supplemental Figure S3) and cODDD mice (Figure 3, I and J;
Supplemental Figure S3). Marrow area was also increased in both
mutant mice (Supplemental Figure S3, A and C), though the differences were larger in the cKO than in the cODDD (43 ± 5% vs. 30 ±
6% relative to WT, respectively). Cortical thickness was significantly
decreased in both cKO (41 ± 11% of WTfl) and cODDD mice (20 ±
7% of WTod) (Figure 3, E and K). Accordingly, the calculated crosssectional moment of inertia was significantly increased in the Cx43
cKO compared with WTfl (Supplemental Figure S3, B and D), suggestive of a greater resistance to mechanical strain in the anterior/
posterior direction. However, direct assessment of resistance to
load, in a three-point bending test to failure, produced rather the
opposite results, as ultimate force to failure was lower in cKO compared with WT bones (Supplemental Figure S3E). Although the differences were not significantly different, most cKO bones bent in
half without breaking. Because of this unexpected outcome, we also
assessed yield force, a point at which further load will cause permanent deformation. This measurement was significantly lower in the
cKO compared with WTfl (Figure 3F). Similar trends were obtained
with the cODDD bones, although the differences against WTod
were not statistically significant (Figure 3L and Supplemental Figure
S3F). Unlike the Cx43 cKO bones, all the bones from the cODDD
mice did break in the three-point bending test.

Changes in bone formation rates in cKO mice
Because the skeletal phenotypes of cKO and cODDD mice were
similar, from this point on we present data for the cKO mice only, as
Molecular Biology of the Cell

surface (Figure 4, B and C). To determine
the overall impact of this shift of bone formation from the endosteum to the periosteum, we measured serum osteocalcin levels, a biochemical marker of bone formation.
Significantly higher (>40%) serum osteocalcin was detected in Cx43-deficient mice
relative to WTfl (Figure 4D), suggesting an
exuberant periosteal bone formation in the
face of decreased bone formation at the endosteal surface.

Altered cortical bone matrix and
hypomineralization in cKO mice
The decreased bone strength of Gja1 mutant bones, in spite of an increased geometric moment of inertia, implies an abnormality in the material properties of mutant
bones. Using a Masson’s trichrome stain, we
excluded an increased osteoid thickness in
cKO bones, thus ruling out osteomalacia as
a potential cause of the decreased bone
strength (Figure 5A). Interestingly, the cell
layer on the periosteal surface was more
prominent in cKO than in WTfl sections,
consistent with increased osteoblast activity
on the periosteum. Low-magnification crosssections of the femur confirmed the larger
size, increased marrow area, and thinner
cortex and also revealed increased cortical
porosity in the Cx43 cKO bones, with large
areas of the cortex undergoing a process of
spongiosation (Figure 5B). Analysis of tibial
cortical sections under polarized light after
picrosirius red staining revealed more disorganized birefringence, especially on the periosteal surface of cKO sections, reflective of
disorganized collagen fibers and an appearance of woven bone (Figure 5C). Quantification of the birefringence pattern revealed
that fiber orientation in the WTfl bones clusFigure 2: Low bone mass and delayed mineralization in cKO and cODDD mice. (A) Alizarin red tered around 90 degrees, as expected;
wheareas in the cKO bone, collagen fiber
and alcian blue stained newborn whole mounts showing malformed, hypoplastic cranial vault
and smaller thoracic cage in cKO compared with WTfl littermates. (B) Skull hypomineralization
orientation was highly variable and spread
but no dysmorphic features are seen in cODDD newborn mice compared with WTod littermates. across the whole range (Figure 5D). Further
(C) MicroCT reconstructions of skulls from 1-mo-old cKO mice showing hypoplastic parietal,
quantification of the degree of disorder of
interparietal, and occipital bones compared with WTfl litermates; but (D) normal mineralization
collagen bundles revealed that enthropy
in cODDD skulls compared with WTod. (E) Whole-bone mineral density, monitored by DXA at
was 3.98 ± 0.57 in cKO, compared with
monthly intervals is significantly lower in cKO and (F) cODDD relative to their comparative WT
2.90 ± 0.024 in WTfl (P < 0.05), respectively,
littermates up to 4 mo of age, with a trend toward partial recovery at later time points
about a 40% difference. On the basis of
(*, P < 0.05 for Gja1 mutants vs. comparative WT, 2-way ANOVA; n = 10).
such abnormalities in collagen fiber organization, we measured the abundance of gene
they exhibit more severe phenotypic changes. Representative fluoproducts known to be involved in extracellular collagen processing,
rescent micrographs of calcein-labeled longitudinal sections of corusing RNA extracted from femurs from which the bone marrow had
tical bone show a dramatic difference in the size and distribution of
been removed. Interestingly, lysyl oxidase (Lox) mRNA was signifidouble labels. Whereas in the WTfl, double labels were only seen in
cantly reduced in Cx43 cKO mice (∼57%) compared WTfl mice,
the endocortical surface, in the mutant bones, double labels were
whereas procollagen lysyl hydroxylase (Plod) and prolyl 3-hydroxyabundant on the periosteal surface, more than in the endosteum
lase (P3HA4) were unchanged (Figure 5E). By μCT, mineral density in
(Figure 4A). Accordingly, dynamic indices of bone formation (BFR/
the cKO cortical bone was significantly reduced (−9 ± 2%) relative to
BS and MAR) calculated from the growth plate to mid-diaphysis of
WTfl (Figure 5F). Despite decreased lox mRNA, we found no major
the femur were significantly reduced on the endosteal surface of
abnormality in collagen cross-linking in cKO bones but rather a decKO bones, whereas they were strikingly increased on the periosteal
crease in collagen mRNA abundance (not shown). Fourier transform
Volume 22 April 15, 2011
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Figure 3: Altered bone structure and strength in Gja1 mutants. (A) MicroCT (μCT) reconstructions of femurs from
1-mo-old WTfl and cKO mice showing shorter, tubular femoral shafts with larger medullary cavities. (B) Femur length is
significantly reduced in the cKO relative to their littermate WT controls. (C) Cross-sections of femurs at middisphysis by
μCT revealing a wider cortical bone section and marrow cavity of cKO femurs relative to WTfl. (D) Tissue area is
significantly higher and (E) cortical thickness is significantly lower in cKO compared with WTfl. (F) Yield force, measured
using a three-point bending test, is reduced relative to WTfl. (G) μCT reconstructions of femurs from 1-mo-old WTod
and cODDD mice. (H) Femur length is significantly reduced in cODDD mice relative to their littermate WT controls.
(I) Cross-sections of femurs at middisphysis by μCT revealing a wider cortical bone section and marrow cavity of cODDD
femurs relative to WTod. (J) Tissue area is significantly higher and (K) cortical thickness is significantly lower in cODDD
compared with WTod. (L) Yield force is not significantly different in cODDD, compared with WTod (*, P < 0.05, vs. WT;
t-test for unpaired samples, n = 5).

infrared spectroscopy (FTIR) analysis of bone samples from the KO
animals suggested that cKO femurs are less mineralized relative to
WTfl, and the mineral appeared less mature (Supplemental Figure
S4), although these differences were not significant.

Abnormal osteoblast differentiation and function
in cKO mice
To investigate the cellular and molecular mechanisms leading to the
phenotype of Cx43-deficient mice, we profiled gene expression in
cortical bone cells of mutant and wild-type mice using real-time
quantitative PCR. Cortical bone extracts (excluding the bone marrow, but including the periosteum) confirmed a greater than 80%
decrease in Gja1 expression (Figure 6A), consistent with Gja1 recombination in vivo (see Figure 1). There was no difference in Runx2
mRNA abundance; but other osteoblastic genes, all down-stream of
Runx2, were down-regulated in cKO bones relative to WTfl, including Osx (42%), Alpl (31%), and Col1A1 (41%), although OPN and
BSP mRNA were unaffected (Figure 6A). Furthermore, mRNA abundance for osteocyte genes Dmp1 and Sost was also significantly
reduced in cKO (42% and 62%, respectively; Figure 6B). However,
the number of osteocytes per cortical surface area was not different
between cKO mice and WTfl (Figures 5A and 6C). Because DM-1
induces Gja1 ablation early in the chondro-osteogenic lineage, we
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performed CFU assays to determine whether the number of stromal
cell precursors was also affected by Gja1 deletion. Intriguingly, the
number of CFU-fibroblast, an index of stromal uncommitted precursors, was significantly increased in the cKO relative to WTfl bone
marrow (Figure 6, D and E). Even more surprisingly, the number of
CFU-osteoblast, an index of osteogenic precursors, was also increased in the mutant animals (Figure 6, F and G). Finally, cell proliferation rate was almost fourfold higher in cKO than in WTfl bone
marrow stromal cells (Figure 6H).

Increased osteoclastogenesis and bone resorption
in cKO mice
Bone marrow cavity expansion, a feature common to both cKO and
cODDD mice, implies increased endocortical bone resorption. Consistent with this hypothesis, we found the number of endocortical
TRAP+ osteoclasts per bone perimeter to be three- to fourfold
higher in cKO bones than in WTfl (Figure 7, A and B). Serum levels
of C-terminal telopeptides of type I collagen, a biochemical marker
of bone resorption, were significantly higher in cKO than in WTfl
mice, confirming that the increased endocortical osteoclast number
reflects increased bone resorption (Figure 7C).
Because Gja1 ablation in this cKO model occurs specifically
in cells of the osteoblast lineage, we determined whether the

Molecular Biology of the Cell

DISCUSSION
These studies demonstrate that ablation of
Gja1 or replacement of one wild-type Gja1
allele with a mutant linked to ODDD in
chondro-osteoprogenitor cells causes a high
bone turnover phenotype with increased
periosteal bone formation, but abnormal
osteoblast function and indirect endocortical osteoclast activation. This leads to agedependent cortical bone expansion, cortical
thinning, and deposition of abnormal bone
tissue. Thus Cx43 controls both arms of
bone remodeling via the osteoblast.
In previous work, we have ablated Gja1
in committed osteoblasts and osteocytes
and found that these mice are osteopenic
and have functionally defective osteoblasts
(Chung et al., 2006), widened diaphysis of
long bones, and decreased bone strength
(Grimston et al., 2008). Here, using the DM1
promoter to obtain a broader and earlier
Gja1 ablation, we observe a similar but more
severe phenotype, as well as developmental abnormalities, such as hypoplastic, hypomineralized skulls, smaller thoracic cavities, and shorter limbs. Such dyspmorphic
features are similar to those observed in
Figure 4: Altered cortical bone formation in cKO mice. (A) Fluorescence micrographs of
germline Gja1 null mice (Lecanda et al.,
calcein labels on the cortical surfaces of WTfl and cKO femurs at 1 mo of age. Double label is
seen only on the endocortical surface of the WTfl bone, whereas abundant double label is seen
2000). At variance with our previous obseron the periosteal surface and to a lesser extent on the endosteum of cKO bone. (B) Bone
vations (Chung et al., 2006), we found very
formation rate and (C) mineral apposition rate are decreased on the endosteal surface in cKO
low, if any, expression of LacZ in trabecular
bones, whereas they are both significantly higher on the periosteal surface of mutant mice
bone cells of cKO mice. The reasons for
relative to WTfl controls (*, P < 0.05, t-test for unpaired samples, n = 4). (D) Serum osteocalcin
such discrepancy are unclear but could be
levels, from 1-mo-old mice, are significantly increased in the cKO relative to WTfl (*, P < 0.05,
related to either low Gja1 expression in trat-test for unpaired samples, n = 7–8).
becular bone or lower efficiency of Cre activity on the Gja1 allele than on the ROSA26
increased osteoclast number reflects an indirect effect of the
reporter allele. Interestingly, in mice where Gja1 was deleted using
mutant osteoblast. First we verified that bone marrow–derived
the Bglap promoter, the phenotype is also restricted to cortical
macrophages (used as osteoclast precursors) from both WTfl
bone (Plotkin et al., 2008; Bivi et al., 2009). Hence larger diaphyseal
and cKO mice produced similar numbers of osteoclasts when
cross-sectional area and cortical thinning are the most consistent
grown in the presence of M-CSF and RANKL (Figure 7, D and
phenotypic changes present in adult Gja1 cKO mice, now reported
E). We also verified by Western blot analysis that Gja1 ablation
in three difference genetic models. Similar cortical abnormalities are
does not occur in the osteoclast lineage of cKO mice, as both
seen in cODDD mice and were also evident in Gja1Jrt/+ mice, a mucKO and WTfl macrophages and multinucleated TRAP+ cells
tant with a phenotype closely resembling ODDD (Flenniken et al.,
express Cx43 (Figure 7F). Next we examined expression of os2005), further proving that modeling of cortical architecture is the
teopotegerin (Opg) and Rankl, two key osteoclast regulators
main function of Cx43 in adult bone.
produced by osteoblasts. Whereas expression of Rankl mRNA
Our studies show that this phenotype is the result of a complex
was unaltered in cKO mice, the abundance of Opg mRNA, an
mechanism involving both arms of the bone remodeling cycle. Corinhibitor of osteoclastogenesis, was significantly down-regulated
tical bone expansion is primarily due to accelerated endocortical
in cKO relative to WTfl mice (Figure 7G). We then tested the
bone resorption, leading to widening of the medullary cavity, which
osteoclastogenic potential of wild-type and mutant osteoblastic
is only partially compensated for by an exuberant periosteal bone
cells by coculturing bone marrow–derived stromal cells with
apposition resulting in a larger periosteal perimeter but thinner cormacrophages isolated from either cKO or WTfl mice. When
tices. Earlier in vitro studies have postulated a role of Cx43 in osteostromal cells derived from WTfl mice were used to support in
clast function (Ransjo et al., 2003; Matemba et al., 2006). However,
vitro osteoclastogenesis, similar numbers of osteoclasts formed
our genetic modification excludes osteoclasts, and the coculture
regardless of the osteoclast precursor genotype. However, when
studies establish that the exuberant osteoclastogenesis is entirely
either cKO or WTfl macrophages were cocultured with cKO
dependent on Cx43-deficient osteoblast-supporting cells, which
stromal cells, a fourfold higher number of multinucleated TRAP+
produce an abnormally low abundance of Opg, a key inhibitor of
osteoclasts were obtained (Figure 7, H and I). Thus it is an
osteoclast differentiation. Further evidence that an abnormal OPG/
abnormality in the stromal/osteoblast lineage that determines
RANKL balance is a key mechanism of the Gja1 cKO phenotype is
the increased osteoclastogenesis observed in Cx43-deficient
provided by the finding that addition of exogenous osteoclastomice.
genic factors, M-CSF and RANKL, to the cocultures offsets the
Volume 22 April 15, 2011
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difference in osteoclastogenesis between
WTfl and cKO cells.
The increased periosteal bone apposition detected in cKO long bones contrasts
with decreased endosteal bone formation,
also present in Gja1 ablated mice driven by
the Col1A1 promoter (Chung et al., 2006;
Grimston et al., 2008), and accounts for the
progressive diaphyseal cross-section expansion, perhaps representing a compensatory
reaction to increased endosteal bone erosion. The mechanism leading to the endosteal-to-periosteal bone formation shift
remains to be elucidated, though our data
suggest a possible link to reduced expression of Sost, an inhibitor of Wnt signaling
(Krishnan et al., 2006). Notably, Sost-deficient mice exhibit cortical thickening and
increased tissue area with increased periosteal and endosteal bone apposition (Li
et al., 2008; Lin et al., 2009). Diaphyseal expansion in cKO mice is not present at birth
but develops with age, and may reflect an
impaired ability of Cx43-deficient animals to
adapt to environmental factors. Cx43-deficient mice are less sensitive to anabolic mechanical load (Grimston et al., 2008) and
skeletal unloading (Grimston et al., unpublished data); and Cx43 has been implicated
in mechanotransduction, primarily in osteocytes (Cherian et al., 2005; Genetos et al.,
2007). This loss of sensitivity to mechanical
stimuli may be the fundamental mechanism
by which Cx43 loss leads to age-dependent
changes in cortical bone. Intriguingly, sclerostin-deficient mice are also insensitive to
in vivo mechanical skeletal unloading (Lin
et al., 2009), reinforcing the hypothesis
that Cx43 may regulate adaptive responses
to mechanical stimuli via modulation of
sclerostin production.
Not only is cortical bone thinner in the
cKO, the quality of the bone tissue is also
abnormal, with disorganized collagen fibers, increased porosity, and decreased
mineralization. All these factors may explain
the reduced bone strength and stiffness

Figure 5: Abnormal cortical bone properties in cKO mice. (A) At 1 mo of age, Goldner
trichrome stain show thinner cKO cortices relative to WTfl, but no abnormal osteoid. Also note
the prominent osteoblast layer in the periosteum (black arrow) and endosteum (white arrow) in
cKO sections. (B) Low-magnification Goldner trichrome-stained cross-sections showing increased
cortical porosity and larger cross-sections in cKO bone relative to WTfl. (C) Birefringence of
picrosirius red stained cortical sections show more collagen disorganization and a woven bone
aspect in cKO relative to WTfl, especially on the periosteal side. (D) Collagen fiber orientation
was quantitated by measuring the angle of extinction of polarized light in picrosirius red stained
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sections. Whereas collagen fiber orientation
clusters around 90 degrees in the WTfl, there
is a wide, uneven spread of collagen fiber
orientation across the whole range (n = 4).
(E) Quantitative real-time PCR of femoral
bone (without bone marrow) RNA extracts,
revealing lower abundance of Lox mRNA, but
unchanged Plod and P3HA4 mRNA in cKO
relative to WTfl. (F) Cortical bone mineral
density (gHA/cc) measured by μCT showing a
significant reduction in the cKO relative to
WTfl (*, P < 0.05 vs. WTfl, t-test for unpaired
samples; n = 4–6).
Molecular Biology of the Cell

Figure 6: Abnormal osteoblast differentiation and function in cKO mice. (A) Quantitative real-time PCR on RNA
extracts from 3-mo-old femurs after bone marrow removal. Data are normalized to Cphn and expressed as mRNA
abundance relative to WTfl bones. Many, though not all osteoblast genes are down-regulated in cKO bones.
(B) Quantitative real-time PCR on cortical bone reveals significantly lower Dmp1 and Sost mRNA abundance in cKO
bones. (C) The number of osteocyte per cortical area, assessed in Masson trichrome-stained, 1-mo-old sections is not
different between WTfl and cKO femurs. (D) Unfractionated, adherent bone marrow cells were isolated, grown for 14 d
at different seeding densities, and stained with Giemsa for CFU-F analysis, as detailed in Materials and Methods. (E) At
each seeding density, there is a significantly higher CFU-F number (colonies with >50 cells) in cKO than in WTfl cultures.
Each well represents 1 of 24 replicates at the corresponding seeding densities. (F) Bone marrow cells were similarly
isolated, but cultured in mineralizing medium for 21 d, before alizarin red staining. (G) The percentage of wells that
mineralized was used as an index of CFU-O, and this percentage is higher in cKO than in WTfl at each seeding density.
Each group of nine wells is representative of each of the three seeding densities used. (H) Unfractionated, adherent
bone marrow cells were assayed for BrdU incorporation over a 6-h period, using a chemiluminescent detection system.
BrdU incorporation is about threefold higher in cKO than in WTfl cultures (*, P < 0.05, vs. WTfl; t-test for unpaired
samples; n = 3 or 4).

despite the increased geometric moment of inertia of the larger
cKO diaphyses. Whereas increased porosity underlies enhanced
bone resorption, analysis of the material properties of cKO bones
did not reveal major qualitative defects in either the mineral or
organic phase. The emerging picture is that of a hypomineralized,
woven, and immature bone, which might be the consequence of
accelerated remodeling and inefficient matrix production response
by Cx43-deficient osteoblasts. Alternatively, the accelerated periosteal bone formation (and endosteal bone resorption) might
represent a mechanism to increase bone strength in response to
this defective bone matrix in cKO mice. Regardless of whether the
increased cortical turnover is the cause or a consequence of the
abnormal material properties of cKO bones, a primary osteoblast
defect is the cause of the entire phenotype.
Many osteoblast gene products are down-regulated in the
cKO in addition to Opg, including Osx, Bglap, and Alpl, but not
Volume 22 April 15, 2011

Runx2. Because Gja1 is ablated early in the chondro-osteogenic
lineage, before Runx2 expression, these results indicate that
Cx43 regulates progression of osteoblast differentiation at the
Runx2-Osx transition, resulting in down-regulation of most
downstream osteoblast genes consistent with previous findings
(Lecanda et al., 2000; Chung et al., 2006). Interestingly, Cx43
enhances Runx2 phosphorylation, DNA binding activity, and
Runx2-mediated gene transcription (Lima et al., 2009). Osteocyte-specific genes, Dmp1 and Sost, are also down-regulated in
the cKO and may be part of this osteoblastic defect. However,
cKO bone marrow stromal cells (BMSCs) exhibit significantly
higher proliferative capacity, likely resulting in the increased number of bone marrow uncommitted precursors and osteoprogenitors. Higher proliferative activity may also explain the increased
number of periosteal cells and the increased periosteal bone formation rate.
Cx43 regulates bone formation/resorption
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Figure 7: Increased osteoclastogenesis and bone resorption in cKO mice. (A) Sections
of cortical bone from 1-mo-old mice showing endocortical TRAP+ cells of both WTfl and
cKO bones (arrows). (B) The number of osteoclasts (multinucleated TRAP+ cells) on the
endocortical surface is significantly higher in cKO than in WTfl. (C) Serum C-terminal
telopeptides of type I collagen is also increased in cKO relative to WTfl. (D) Osteoclast
precursors (macrophages) isolated from either cKO or WTfl bone marrow were cultured in
96-well plates for 5 d in the presence of M-CSF and RANKL. (E) No differences in the
number of TRAP+, multinucleated osteoclasts were observed between genotypes.
(F) Macrophages (Mac) isolated from either cKO or WTfl bone marrow and cultured
for 5 d in the presence of M-CSF, and osteoclasts (OC), obtained by further incubation of
macrophages with M-CSF and RANKL, were lysed for immunoblotting. Cx43 expression
was lower in mature osteoclasts relative to macrophages in both genotypes with no
difference between genotypes. (G) The abundance of Opg mRNA, assessed by
real-time PCR in extracts from femurs (without bone marrow), is lower in cKO
relative to WTfl, whereas Rankl mRNA is not different. (H) Osteoblasts and osteoclast
precursors isolated from either cKO or WTfl bone marrow were cocultured in 24-well
plates for 7 d in medium supplemented with vitamin D and dexamethasone, for
development of TRAP+, multinucleated osteoclasts. (I) Osteoblasts from WTfl mice
support the same number of osteoclastic cells regardless of the genotype of the
osteoclast precursors, whereas when cKO osteoblasts are used, a higher number of
osteoclast form regardless of the osteoclast precursor genotype (*, P < 0.05,
vs. WTfl, t-test for unpaired samples, n = 5-8; †, P < 0.05 vs. WT OB; Tukey test;
n = 4).
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Introduction of the G138R Gja1 mutation, linked to ODDD, in chondo-osteogenic
cells recapitulates the most relevant skeletal
features of cKO mutants. This phenotype is
caused by replacement of a single wild-type
allele, and because Gja1 heterozygous null
mice have a normal skeleton (Lecanda
et al., 2000; Chung et al., 2006), the G138R
Gja1 mutant is indeed dominant-negative
for Cx43, as postulated by in vitro studies
(Roscoe et al., 2005). Furthermore, as this
mutant has also been shown to enhance hemichannel function (Gong et al., 2007;
Dobrowolski et al., 2008), our results argue
against the hypothesis that hemichannel activity is involved in bone turnover modulation. Severe whole-body osteopenia and
larger but thinner femoral diaphyses were
also observed in other ODDD mouse models (Flenniken et al., 2005; Dobrowolski
et al., 2008). Intriguingly, osteopenia has
never been described in patients with
ODDD, who are typically reported as
having hyperostosis of the cranial vault
(Loddenkemper et al., 2002; Paznekas
et al., 2003; Kjaer et al., 2004). These discrepancies may reflect species-related differences, though bone mass measurements
have never been reported in ODDD patients. However, broad tubular bones are
frequently observed in ODDD patients, and
this feature may indeed reflect the cortical
bone expansion and attendant high bone
remodeling emerging from this study.
In summary, Cx43 modulates both arms
of the bone-remodeling cycle in adult bones
via cell autonomous and noncell autonomous actions, causing indirect activation of
endocortical osteoclasts and resulting in
age-dependent cortical bone expansion
and cortical thinning. This is not effectively
compensated by increased periosteal bone
formation, as the material properties of the
newly formed bone are abnormal, resulting
in compromised bone strength. Such
changes are remindful of those that occur in
aging and disuse osteoporosis.

MATERIAL AND METHODS
Transgenic mice
For conditional Gja1 ablation, a mouse
strain harboring a mutant “floxed” Gja1 allele (Gja1flox) (Theis et al., 2001) was mated
to mice expressing Cre under control of the
DM1 promoter (DM1-Cre) (Yu et al., 2003),
resulting in Cre-mediated replacement of
the entire Gja1 reading frame with the LacZ
reporter cassette. To avoid potential effects
of Cre activation in the parental germ line
(Theis et al., 2001), and following a previously described strategy (Chung et al.,
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2006), we crossed Gja1flox/flox mice with DM1-Cre mice also carrying
a Gja1 null allele (DM1-Cre;Gja1+/−). These crosses produce, in approximately equal numbers, Gja1 conditionally deleted mice, DM1Cre;Gja1flox/− (cKO), as well as Gja1flox/+ (wild-type equivalent; WTfl),
Gja1flox/− (heterozygous equivalent), and DM1-Cre;Gja1flox/+ (conditional heterozygous). Since we found that the latter two genotype
groups have no detectable phenotypic abnormalities, only data
from cKO and WTfl are reported here.
To induce an ODDD mutation selectively in chondro-osteoprogenitor cells, we mated DM1-Cre with Gja1flox(G138R)/flox(G138R) mice, a
kind gift from Klaus Willecke (University of Bonn, Germany). Analogously to the “floxed” Gja1 mutant, Cre-mediated recombination
in the Gja1flox(G138R) mice removes the wild-type Gja1 allele, replacing it with a Gja1 G138R mutant allele (Dobrowolski et al., 2008).
These crosses generate conditional heterozygous mutants, DM1Cre;Gja1flox(G138R)/+ (cODDD), and wild-type equivalent Gja1flox(G138R)/+
(WTod) mice. Because of the gender-specific differences in bone
structure, male and female mice were analyzed separately, but we
present data on male mice as similar results were obtained in both
genders. ROSA26 mice (a generous gift from Henry Kronenberg,
Harvard University, Boston, MA) were mated with DM1-Cre mice to
determine the effectiveness of DM1-driven Cre recombination in
adult mice (Soriano, 1999).
Genotyping was performed by PCR on genomic DNA extracted
from mouse tails using the HotSHOT method (Truett et al., 2000).
We used previously described methods to detect the Gja1 null,
wild-type, floxed alleles (Chung et al., 2006) and Gja1flox(G138R) alleles
(Dobrowolski et al., 2008), as well as the DM1-Cre (Liu et al., 2002)
and ROSA26 transgenes (Mao et al., 1999).
All the mouse lines used in this project were developed in a
mixed C57BL/6-C129/J background, and littermates were used as
controls. Mice were fed regular chow ad libitum and housed in a
room maintained at constant temperature (25°C) on a 12-h light and
12-h dark schedule. All procedures were approved by the Animal
Studies Committee of Washington University in St. Louis.

Whole body mounts
Newborn mice were stained with alizarin red and alcian blue as previously described (Chung et al., 2006).

−80°C for later assays. Bone samples were prepared as previously
described with some modifications (Chung et al., 2006). Quantitative histomorphometry was performed as detailed elsewhere
(Castro et al., 2004; Grimston et al., 2006). Some undecalcified sections were stained with a Goldner’s modified trichrome technique,
which was also used on thick (80 μm) sections to visualize cortical
porosity (Hirano et al., 2000).
Some decalcified bone samples were processed for β-gal staining as detailed (Chung et al., 2006), with the addition of 100 mM
galactose to the staining solution to quench nonspecific staining.
To study collagen fiber orientation, paraffin sections were stained
in 0.1% picrosirius red solution, destained in 1% (v/v) acetic acid,
and counterstained with hematoxylin. The samples were visualized
on a polarized light microscope (Olympus BX51P; Olympus, Tokyo, Japan), and images were analyzed as previously described
(Thomopoulos et al., 2006).

Bone marrow stromal progenitor cells
We used a modification of a previously described method (Castro
et al., 2004; Di Benedetto et al., 2010). The entire marrow cavity
of the shafts (femora and tibiae) of 3-mo-old mice was flushed
by removing one of the epiphyses and centrifuging the bone at
10,000 rpm for 15 s. After hemolysis in a red blood cell lysis buffer
(Roche Applied Science, Mannheim, Germany), the material was resuspended in αMEM (Mediatech, Herndon, VA) and filtered through
a 70-μm cell strainer. Cells were resuspended in αMEM containing
20% fetal calf serum (FCS) and antibiotics and plated in 96-well tissue culture plates at different seeding densities for determination of
colony forming unit-fibroblast (CFU-F) or -osteoblast (CFU-O). For
CFU-F, cells were seeded in αMEM supplemented with 20% FCS.
The number of CFU-F was determined after 14 d of culture by fixation in ethanol and staining with Giemsa. Colonies containing more
than 50 cells were counted. For CFU-O assessment, cells were
seeded in α-MEM supplemented with 20% FCS, 50 μM ascorbic
acid, and 10 μM β-glycerophosphate. Cells were cultured for 21 d,
then fixed in 50% ethanol/18% formaldehyde, and stained for mineralized matrix using alizarin red. Wells that stained were counted
positive for mineralization, and the percentage of the 24 replicate
wells in each plate that mineralized was calculated for all cell densities. All CFU experiments were undertaken in triplicate.

Bone mass and microstructure
Whole-body bone mineral content and BMD were monitored by
DXA using a PIXImus scanner (GE/Lunar, Madison, WI) under anesthesia as previously described (Castro et al., 2004). Analysis of femoral bone structure was performed using a μCT system (μCT 40;
Scanco Medical AG, Zurich, Switzerland), as also previously described (Grimston et al., 2008; Di Benedetto et al., 2010). μCT of
skulls from 1-mo-old mice were also performed. Skulls were stabilized in 1.5–2.0% agarose gel and scanned using 45 EkVp radiation
energy at standard resolution (20 μm). About 250 images were used
for 3D reconstruction.

Bone biomechanics
Mechanical testing in a three-point bending to failure was conducted on femora after μCT scanning as described previously (Di
Benedetto et al., 2010).

Bone histology and histomorphometry
Mice were labeled twice by injection of calcein (15 mg/kg i.p.;
Sigma-Aldrich, St. Louis, MO) 7 and 2 d before euthanasia, which
was performed under light anesthesia by exsanguination through
dorsal aortic puncture. Blood was collected and the serum stored at
Volume 22 April 15, 2011

Osteoclast cultures
The marrow cavity was flushed as described above. Cells were
resuspended in αMEM (Mediatech, Manassas, VA) and filtered
through a 70-μm cell strainer. Cell were resuspended in αMEM
containing 10% FCS, antibiotics, and 100 ng/ml M-CSF and
cultured for 5 d, with media being replenished every second
day. Thereafter, resultant macrophages were released and 3.0 × 105
cells seeded in a 96-well plate in α-MEM supplemented with 10%
fetal bovine serum (FBS), 10 ng/ml M-CSF, and 100 ng/ml RANKL.
Cells were grown for 7 d and then stained for TRAP using the
Leukocyte Acid Phosphatase kit (Sigma-Aldrich, St. Louis, MO).
The number of multinucleated, TRAP+ cells was determined as
index of osteoclastogenesis.

Stromal cell-macrophage cocultures
BMSCs were isolated as described above, resuspended, and cultured in α-MEM supplemented with 10% FCS for 24 h. Nonadherent
cells, which include macrophages, were removed and replated in a
separate Petri dish in α-MEM supplemented with 10% FCS that favors macrophage growth. Adherent cells were cultured for 7 d in
α-MEM supplemented with 20% FCS to stimulate proliferation of
Cx43 regulates bone formation/resorption
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BMSCs. Thereafter, stromal cells and macrophages were released
from their respective dishes, mixed (3.4 × 105 each), and seeded in
a 24-well plate in α-MEM supplemented with 10% FBS, 10 nM vitamin D3, and 100 nM dexamethasone (Wang et al., 2004). These
cocultures were incubated for 7 d and then stained for TRAP as described above.

10 mM EDTA for 5 min at 37°C. Proteins were separated on 8%
Tris-glycine SDS gel and transferred to Immobilon membranes
(Millipore, Billerica, MA). The membrane was probed with antibodies against Cx43 (C6219; Sigma-Aldrich), β-gal (ab616; Abcam,
Cambridge, MA), and α-tubulin (sc-8035; Santa Cruz Biotechnology,
Santa Cruz, CA).

Cell proliferation

FTIR analysis

BMSCs were isolated as described above, counted, and seeded in
α-MEM supplemented with 20% FBS on a black-sided, 96-well tissue culture plate. Twenty-four hours later, the cells were labeled with
BrdU, and incorporation was quantified using a chemiluminescent
Cell Proliferation ELISA kit as per manufacturer’s instructions (Roche
Applied Science, Mannheim, Germany).

Femur midshafts from WTflx and cKO animals were collected, soft
tissues removed, and the bone marrow removed by centrifugation
and the samples lyophilized. The samples were pulverized and
studied in transmission mode in KBr pellets using Bucker Vertex 70
FTIR spectrometer (Millipore, Billerica, MA). The spectra were collected with the resolution of 2 cm−1 with 32 scans collected per each
spectrum.

Real-time quantitative PCR
Total RNA was extracted from whole bones that had been flushed
of bone marrow as described above and flash frozen in liquid nitrogen. Bones were pulverized using a Braun Mikrodismembrator
(Sartorius Stedim Biotech S.A., Aubagne, France). Total RNA was
extracted using TRIzol reagent (Invitrogen, Carlsbad, CA) and further purified using Phase-Lock gel tubes (5 Prime, Hamburg,
Germany) and Qiagen RNA Easy kit (Qiagen, Valencia, CA) as per
the manufacturer’s instructions. Contaminating DNA was removed
by RNase-free DNase (Qiagen, Valencia, CA) treatment. mRNA
was quantified following previously described methods (Stains
et al., 2003; Mbalaviele et al., 2005), and 1 μg total RNA was
reverse transcribed using a Superscript VILO cDNA synthesis kit
(Invitrogen, Carlsbad, CA). Real-time PCR analysis performed in
an Applied Biosytem 7500 Fast detector system using the SYBR
green PCR method according to manufacturer’s instruction
(Applied Biosystems, Foster City, CA). The mean cycle threshold
value (Ct) from triplicate samples was used to calculate gene expression, and PCR products were normalized to Cphn levels for
each reaction. Relative gene expression levels were determined
as described in User’s Bulletin (P/N 4303859) from Applied Biosystems. Primer sets are detailed in Supplemental Table 1. Taqman
Gene expression assays (Applied Biosystems) were used for quantification of Dmp1, Lox, Plod, and P3ha4, according to manufacturer’s instruction (Applied Biosystems).

Biochemical markers of bone turnover
Serum C terminus Cross-Linked Telopeptides of Type I Collagen
(CTX) and osteocalcin were measured as indices of bone resorption
and formation, respectively. For these assays, serum was obtained
from mice that had been deprived of food and water for 6 h. Analyses were performed by ELISA, using a CTX (RatLaps EIA; Immunodiagnostics Systems, Fountain Hills, AZ) and the osteocalcin kit (Mouse
Osteocalcin EIA Kit; Biomedical Technologies, Stoughton, MA), according to the manufacturer’s instructions.

Immunoblotting
Protein extracts were prepared from whole bones that had been
flushed of bone marrow and processed as described earlier. The
pulverized bone was incubated in 50 mM Tris, pH 8.0, 150 mM
NaCl, 2 mM EDTA, 1% Triton-X, 0.1% SDS, 0.5% sodium deoxycholate, 2 mM NaVO4, 10 mM NaF, and protease inhibitors at 4°C
for 10 min then centrifuged at 12,000 g for 20 min. Total protein
concentration was measured using the BCA method (Pierce, Rockford, IL) and normalized against extraction buffer. Protein from osteoclast cultures was isolated using the same method, after removal
of adherent stromal cells from six-well cultures by incubation with
1250 | M. Watkins et al.

Statistical analysis
Groups means were compared by t-test for unpaired samples. Data
on repeated measures were analyzed by analysis of variance
(ANOVA). Data were analysed using SigmaPlot Vs11.0 (Systat Software GmbH, Germany). All data are expressed as the mean ± SD.
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